ヒト絨毛性ゴナドトロピン（HCG）の世界市場：インサイト・予測

• 英文タイトル：Global Human Chorionic Gonadotropin (HCG) Market Insights, Forecast to 2025

• レポートコード：QYR9ST00172
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、113ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートでは、世界のヒト絨毛性ゴナドトロピン（HCG）市場について調査・分析し、以下の構成でお届け致します。ヒト絨毛性ゴナドトロピン（HCG）の種類別には、天然源抽出、組換えDNAテクノロジーに、用途別には、女性不妊治療、乏精子治療、停留精巣治療、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別ヒト絨毛性ゴナドトロピン（HCG）売上データ
・地域別ヒト絨毛性ゴナドトロピン（HCG）市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別ヒト絨毛性ゴナドトロピン（HCG）市場規模：天然源抽出、組換えDNAテクノロジー
・用途別ヒト絨毛性ゴナドトロピン（HCG）市場規模：女性不妊治療、乏精子治療、停留精巣治療、その他
・主要メーカーの企業情報：EMD Serono, Inc、Ferring B.V、Merck & Co., Inc、Bristol Myers Squibb Company、Fresenius Kabi AG, LLC、Scrippslabs、Leebio、Kamiya Biomedical Company、Sanzyme、Cigna
・ヒト絨毛性ゴナドトロピン（HCG）の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology. The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.
The global Human Chorionic Gonadotropin (HCG) market is valued at 390 million US$ in 2018 and will reach 620 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Chorionic Gonadotropin (HCG) market based on company, product type, end user and key regions.

This report studies the global market size of Human Chorionic Gonadotropin (HCG) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Chorionic Gonadotropin (HCG) in these regions.
This research report categorizes the global Human Chorionic Gonadotropin (HCG) market by top players/brands, region, type and end user. This report also studies the global Human Chorionic Gonadotropin (HCG) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
EMD Serono, Inc
Ferring B.V
Merck & Co., Inc
Bristol Myers Squibb Company
Fresenius Kabi AG, LLC
Scrippslabs
Leebio
Kamiya Biomedical Company
Sanzyme
Cigna

Market size by Product
Natural Source Extraction
Recombinant DNA Technology
Market size by End User
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Human Chorionic Gonadotropin (HCG) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Human Chorionic Gonadotropin (HCG) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Chorionic Gonadotropin (HCG) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Human Chorionic Gonadotropin (HCG) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Human Chorionic Gonadotropin (HCG) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Chorionic Gonadotropin (HCG) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Study Coverage
1.1 Human Chorionic Gonadotropin (HCG) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Product
1.4.2 Natural Source Extraction
1.4.3 Recombinant DNA Technology
1.5 Market by End User
1.5.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by End User
1.5.2 Female Infertility Treatment
1.5.3 Oligospermic Treatment
1.5.4 Cryptorchidism Treatment
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Human Chorionic Gonadotropin (HCG) Market Size
2.1.1 Global Human Chorionic Gonadotropin (HCG) Revenue 2014-2025
2.1.2 Global Human Chorionic Gonadotropin (HCG) Sales 2014-2025
2.2 Human Chorionic Gonadotropin (HCG) Growth Rate by Regions
2.2.1 Global Human Chorionic Gonadotropin (HCG) Sales by Regions
2.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
3.1.1 Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
3.1.2 Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers
3.1.3 Global Human Chorionic Gonadotropin (HCG) Market Concentration Ratio (CR5 and HHI)
3.2 Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers
3.2.1 Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2014-2019)
3.2.2 Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2014-2019)
3.3 Human Chorionic Gonadotropin (HCG) Price by Manufacturers
3.4 Human Chorionic Gonadotropin (HCG) Manufacturing Base Distribution, Product Types
3.4.1 Human Chorionic Gonadotropin (HCG) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
3.4.3 Date of International Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Human Chorionic Gonadotropin (HCG) Sales by Product
4.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Product
4.3 Human Chorionic Gonadotropin (HCG) Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Human Chorionic Gonadotropin (HCG) Breakdown Data by End User

6 North America
6.1 North America Human Chorionic Gonadotropin (HCG) by Countries
6.1.1 North America Human Chorionic Gonadotropin (HCG) Sales by Countries
6.1.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Chorionic Gonadotropin (HCG) by Product
6.3 North America Human Chorionic Gonadotropin (HCG) by End User

7 Europe
7.1 Europe Human Chorionic Gonadotropin (HCG) by Countries
7.1.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Countries
7.1.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Chorionic Gonadotropin (HCG) by Product
7.3 Europe Human Chorionic Gonadotropin (HCG) by End User

8 Asia Pacific
8.1 Asia Pacific Human Chorionic Gonadotropin (HCG) by Countries
8.1.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Countries
8.1.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Human Chorionic Gonadotropin (HCG) by Product
8.3 Asia Pacific Human Chorionic Gonadotropin (HCG) by End User

9 Central & South America
9.1 Central & South America Human Chorionic Gonadotropin (HCG) by Countries
9.1.1 Central & South America Human Chorionic Gonadotropin (HCG) Sales by Countries
9.1.2 Central & South America Human Chorionic Gonadotropin (HCG) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Human Chorionic Gonadotropin (HCG) by Product
9.3 Central & South America Human Chorionic Gonadotropin (HCG) by End User

10 Middle East and Africa
10.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) by Countries
10.1.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Countries
10.1.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) by Product
10.3 Middle East and Africa Human Chorionic Gonadotropin (HCG) by End User

11 Company Profiles
11.1 EMD Serono, Inc
11.1.1 EMD Serono, Inc Company Details
11.1.2 Company Business Overview
11.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Products Offered
11.1.5 EMD Serono, Inc Recent Development
11.2 Ferring B.V
11.2.1 Ferring B.V Company Details
11.2.2 Company Business Overview
11.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Products Offered
11.2.5 Ferring B.V Recent Development
11.3 Merck & Co., Inc
11.3.1 Merck & Co., Inc Company Details
11.3.2 Company Business Overview
11.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Products Offered
11.3.5 Merck & Co., Inc Recent Development
11.4 Bristol Myers Squibb Company
11.4.1 Bristol Myers Squibb Company Company Details
11.4.2 Company Business Overview
11.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Products Offered
11.4.5 Bristol Myers Squibb Company Recent Development
11.5 Fresenius Kabi AG, LLC
11.5.1 Fresenius Kabi AG, LLC Company Details
11.5.2 Company Business Overview
11.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Products Offered
11.5.5 Fresenius Kabi AG, LLC Recent Development
11.6 Scrippslabs
11.6.1 Scrippslabs Company Details
11.6.2 Company Business Overview
11.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Scrippslabs Human Chorionic Gonadotropin (HCG) Products Offered
11.6.5 Scrippslabs Recent Development
11.7 Leebio
11.7.1 Leebio Company Details
11.7.2 Company Business Overview
11.7.3 Leebio Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Leebio Human Chorionic Gonadotropin (HCG) Products Offered
11.7.5 Leebio Recent Development
11.8 Kamiya Biomedical Company
11.8.1 Kamiya Biomedical Company Company Details
11.8.2 Company Business Overview
11.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Products Offered
11.8.5 Kamiya Biomedical Company Recent Development
11.9 Sanzyme
11.9.1 Sanzyme Company Details
11.9.2 Company Business Overview
11.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Products Offered
11.9.5 Sanzyme Recent Development
11.10 Cigna
11.10.1 Cigna Company Details
11.10.2 Company Business Overview
11.10.3 Cigna Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Cigna Human Chorionic Gonadotropin (HCG) Products Offered
11.10.5 Cigna Recent Development

12 Future Forecast
12.1 Human Chorionic Gonadotropin (HCG) Market Forecast by Regions
12.1.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Regions 2019-2025
12.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Regions 2019-2025
12.2 Human Chorionic Gonadotropin (HCG) Market Forecast by Product
12.2.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Product 2019-2025
12.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Product 2019-2025
12.3 Human Chorionic Gonadotropin (HCG) Market Forecast by End User
12.4 North America Human Chorionic Gonadotropin (HCG) Forecast
12.5 Europe Human Chorionic Gonadotropin (HCG) Forecast
12.6 Asia Pacific Human Chorionic Gonadotropin (HCG) Forecast
12.7 Central & South America Human Chorionic Gonadotropin (HCG) Forecast
12.8 Middle East and Africa Human Chorionic Gonadotropin (HCG) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Chorionic Gonadotropin (HCG) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Human Chorionic Gonadotropin (HCG) Product Picture
Table Human Chorionic Gonadotropin (HCG) Market Segments
Table Key Manufacturers Human Chorionic Gonadotropin (HCG) Covered
Table Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Product 2014-2025
Figure Natural Source Extraction Product Picture
Table Major Manufacturers of Natural Source Extraction
Figure Recombinant DNA Technology Product Picture
Table Major Manufacturers of Recombinant DNA Technology
Table Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Female Infertility Treatment
Figure Oligospermic Treatment
Figure Cryptorchidism Treatment
Figure Others
Figure Human Chorionic Gonadotropin (HCG) Report Years Considered
Figure Global Human Chorionic Gonadotropin (HCG) Market Size 2014-2025 (Million US$)
Figure Global Human Chorionic Gonadotropin (HCG) Sales 2014-2025 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Sales by Regions 2014-2019 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions 2014-2019
Figure Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions 2014-2019
Figure 2018 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions
Table Global Human Chorionic Gonadotropin (HCG) Revenue by Regions 2014-2019 (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions 2014-2019
Figure Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions
Table Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturers (2014-2019) (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturers (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2014-2019) (Million USD)
Table Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2014-2019)
Figure Human Chorionic Gonadotropin (HCG) Value Share by Manufacturers in 2018
Table Key Manufacturers Human Chorionic Gonadotropin (HCG) Price (2014-2019) (USD/Unit)
Table Human Chorionic Gonadotropin (HCG) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
Table Date of International Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Share by Product (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Product in 2018
Table Global Human Chorionic Gonadotropin (HCG) Revenue by Product (2014-2019) (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Revenue Share by Product (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Product (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Product in 2018
Table Human Chorionic Gonadotropin (HCG) Price by Product 2014-2019 (USD/Unit)
Table Global Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Share by End User (2014-2019)
Figure Global Sales Human Chorionic Gonadotropin (HCG) Market Share by End User (2014-2019)
Figure Global Sales Human Chorionic Gonadotropin (HCG) Market Share by End User in 2018
Figure North America Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure North America Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table North America Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure United States Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure United States Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Canada Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 North America Human Chorionic Gonadotropin (HCG) Market Share by Product
Table North America Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table North America Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 North America Human Chorionic Gonadotropin (HCG) Market Share by End User
Figure Europe Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure Europe Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table Europe Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure Germany Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Germany Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure France Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure UK Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Italy Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Russia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Human Chorionic Gonadotropin (HCG) Market Share by Product
Table Europe Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Human Chorionic Gonadotropin (HCG) Market Share by End User
Figure Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure China Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure China Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure India Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Australia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Share by Product
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Share by End User
Figure Central & South America Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table Central & South America Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure Brazil Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Human Chorionic Gonadotropin (HCG) Market Share by Product
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Human Chorionic Gonadotropin (HCG) Market Share by End User
Figure Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure GCC Countries Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Share by Product
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Share by End User
Table EMD Serono, Inc Company Details
Table EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table EMD Serono, Inc Recent Development

Table Ferring B.V Company Details
Table Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ferring B.V Recent Development

Table Merck & Co., Inc Company Details
Table Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co., Inc Recent Development

Table Bristol Myers Squibb Company Company Details
Table Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol Myers Squibb Company Recent Development

Table Fresenius Kabi AG, LLC Company Details
Table Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Fresenius Kabi AG, LLC Recent Development

Table Scrippslabs Company Details
Table Scrippslabs Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Scrippslabs Recent Development

Table Leebio Company Details
Table Leebio Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Leebio Recent Development

Table Kamiya Biomedical Company Company Details
Table Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kamiya Biomedical Company Recent Development

Table Sanzyme Company Details
Table Sanzyme Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanzyme Recent Development

Table Cigna Company Details
Table Cigna Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cigna Recent Development

Table Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Regions 2019-2025 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by Regions 2019-2025
Table Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Revenue Market Share Forecast by Regions 2019-2025
Table Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Product 2019-2025 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by Product 2019-2025
Table Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Revenue Market Share Forecast by Product 2019-2025
Table Global Human Chorionic Gonadotropin (HCG) Sales Forecast by End User 2019-2025 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by End User 2019-2025
Figure North America Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Human Chorionic Gonadotropin (HCG) Value Chain
Table Human Chorionic Gonadotropin (HCG) Customers List
Table Human Chorionic Gonadotropin (HCG) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

ヒューマンマシンインターフェース（HMI）の世界市場：インサイト・予測

Global Human Machine Interface (HMI) Market Insights, Forecast to 2025
QYR9ST01541 2019年9月2日 115Pages
※本調査レポートでは、世界のヒューマンマシンインターフェース（HMI）市場について調査・分析し、以下の構成でお届け致します。ヒューマンマシンインターフェース（HMI）の種類別には、ディスプレイ端末、インターフェースソフトウェア、産業用PCに、用途別には、自動車、ヘルスケア、食品及び飲料、石油及びガス...

ヒト成長ホルモン（hGH）の世界市場：市場規模・現状・予測

Global Human Growth Hormone (hGH) Market Size, Status and Forecast 2019-2025
QYR9ST04181 2019年9月2日 94Pages
※当調査レポートでは、ヒト成長ホルモン（hGH）の世界市場について調査・分析し、ヒト成長ホルモン（hGH）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（パウダー、溶剤）、用途別（成長ホルモン欠乏症...

人識別の世界市場：インサイト・予測

Global Human Identification Market Insights, Forecast to 2025
QYR9ST01540 2019年9月2日 113Pages
※本調査レポートでは、世界の人識別市場について調査・分析し、以下の構成でお届け致します。人識別の種類別には、キャピラリー電気泳動、ポリメラーゼ連鎖反応、次世代シーケンス、迅速DNA分析、その他に、用途別には、法医学研究所、病院、委託研究機関、研究機関、その他に、地域別には、北米、アメリカ、ヨーロッパ...

ヒト狂犬病ワクチンの世界市場：インサイト・予測

Global Human Rabies Vaccines Market Insights, Forecast to 2025
QYR9ST02906 2019年9月2日 115Pages
※本調査レポートでは、世界のヒト狂犬病ワクチン市場について調査・分析し、以下の構成でお届け致します。ヒト狂犬病ワクチンの種類別には、ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他に、用途別には、暴露前予防、暴露後予防に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本...

人乳オリゴ糖の世界市場：インサイト・予測

Global Human Milk Oligosaccharides Market Insights, Forecast to 2025
QYR9ST02905 2019年9月2日 113Pages
※本調査レポートでは、世界の人乳オリゴ糖市場について調査・分析し、以下の構成でお届け致します。人乳オリゴ糖の種類別には、フコシルラクトース、LNT及びLNnT、シアリルラクトースに、用途別には、食品及び飲料、栄養補助食品、人間及び動物の健康成分、幼児用フォーミュラに、地域別には、北米、アメリカ、ヨー...

心電計（ECG）の世界市場：インサイト・予測

Global Electrocardiograph (ECG) Market Insights, Forecast to 2025
QYR9ST01960 2019年9月2日 117Pages
※本調査レポートでは、世界の心電計（ECG）市場について調査・分析し、以下の構成でお届け致します。心電計（ECG）の種類別には、ECGシステムの監視、ECGシステムの診断に、用途別には、ホームベースのユーザー、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南...

エリスロポエチン（EPO）の世界市場：インサイト・予測

Global Erythropoietin (EPO) Market Insights, Forecast to 2025
QYR9ST01968 2019年9月2日 116Pages
※本調査レポートでは、世界のエリスロポエチン（EPO）市場について調査・分析し、以下の構成でお届け致します。エリスロポエチン（EPO）の種類別には、エポエチン-アルファ、ダルベポエチン-アルファ、エポエチン-ベータ、その他に、用途別には、貧血、腎臓障害、その他に、地域別には、北米、アメリカ、ヨーロッ...

医薬品有効成分（API）の世界市場：インサイト・予測

Global Active Pharmaceutical Ingredients Market Insights, Forecast to 2025
QYR9ST01860 2019年9月2日 117Pages
※本調査レポートでは、世界の医薬品有効成分（API）市場について調査・分析し、以下の構成でお届け致します。医薬品有効成分（API）の種類別には、合成、バイオテクノロジーに、用途別には、診断研究所、研究及び学術研究所、製薬及びバイオテクノロジー企業に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中...

気道管理製品（AMD）の世界市場：インサイト・予測

Global Airway Management Products (AMD) Market Insights, Forecast to 2025
QYR9ST01262 2019年9月2日 118Pages
※本調査レポートでは、世界の気道管理製品（AMD）市場について調査・分析し、以下の構成でお届け致します。気道管理製品（AMD）の種類別には、非緊急手術手順、ICU /緊急手順に、用途別には、病院、外来手術センター、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド...

骨膠（骨グルー）の世界市場：インサイト・予測

Global Bone Glue Market Insights, Forecast to 2025
QYR9ST00827 2019年9月2日 116Pages
※本調査レポートでは、世界の骨膠（骨グルー）市場について調査・分析し、以下の構成でお届け致します。骨膠（骨グルー）の種類別には、天然ボーングルー、合成ボーングルーに、用途別には、病院、外来手術センター（ASC）、専門クリニックに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、...

人識別の世界市場：インサイト・予測 Human identification falls under forensic science, which helps in identifying persons by using traces left out during accidents, or a crime scene. Human identification basically focuses on detection of ridges present on fingers of the suspect. Various other samples are also included for human identi…
人乳オリゴ糖の世界市場：インサイト・予測 Human milk oligosaccharides are gaining traction due to the potential benefits by consumption such as a prebiotic to maintain a healthy immune system in infants. It also aids in blocking adhesion of microbial pathogens and foreign particles to epithelial surfaces, thus improving gut colonisation.Amo…
不妊検査及び治療の世界市場：市場規模・現状・予測 Fertility testing is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are per…
ヒト狂犬病ワクチンの世界市場：インサイト・予測 Rabies vaccine is a vaccine used to prevent rabies.They can be used to prevent rabies before and for a period of time after exposure to the virus such as by a dog or bat bite.The immunity that develops is long lasting after a full course.Global human rabies vaccines market is expected to witness rob…
ヒトアルブミンの世界市場：市場規模・現状・予測 Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's di…